What Are the Growth Opportunities in Continuous Glucose Monitoring Solutions?
Which regions show vast growth potential? Which technological advances and strategic partnerships are crucial for success? How are the vendors working to increase data integration and device compatibility within the diabetes treatment ecosystem?
Next-Generation Sequencing Informatics: What Are the Key Growth Drivers?
What is the current growth rate of the sector, and what are the growth projections for the next 5 years, globally and regionally? Who are the primary technology solution providers, and their application areas? Which opportunities are rising from this landscape?
Tissue-Engineered Skin Substitute: What Are the Top Growth Opportunities?
What are the emerging applications for skin substitutes and how do they boost growth? How will advanced products like cellular and acellular skin sprays play a significant role when it comes to complex wound healing in the clinical dermatology space?
Soft Tissue Navigation Systems
Is your team capitalizing on the next-generation surgical robotics technologies?
Antibody Drug Conjugates
How will collaborations with innovative platform developers contribute to growth?
Retail Health Transformation
How do retailers' patient-centric approaches and healthcare challenges foster growth?
Outpatient Care Imaging Services
How will radiology services in outpatient care impact the medical imaging sector?
Internet of Things in Healthcare
How do new technologies and interoperability propel the healthcare cybersecurity space?
Oncology and In Vitro Diagnostics
How does leveraging data-driven solutions contribute to enhancing product performance for clients?
Cloud Computing in Healthcare
Which factors drive the adoption of hybrid and multi-cloud solutions in healthcare?
Liquid Dosage Excipients
What are the key segments in the global parenteral excipients sector and their contributions?
Right-shoring and Innovation in Oral Dosage Forms Emerge as Top Growth Opportunities for Small Molecule Contract Development and Manufacturing Organizations (CDMOs)
Managing optimal inventory levels remains vital as CDMOs work on multiple projects simultaneously. This can lead to inventory management issues, including understocking or overstocking of materials, expiration of materials, and increased costs due to inventory holding. With speed and timely delivery of products emerging as primary criteria for partner selection, strategies around minimizing the supply chain issues emerged as vital drivers to growth. Therefore, a multi-sourcing strategy and right-shoring to address cost and efficiency concerns are transforming CDMOs.
Mission Possible: Serving The Vulnerable Tier-2 & 3 Kidney Care Patients
Explore the global campaigns geared toward raising awareness to reduce the frequency and impact of kidney disease and its associated health problems. Find out the major government efforts to expand the overall dialysis network and provide free dialysis services to the poor. Discover how the private sector is fueling the momentum of change.
Top 5 Developments to Watch in the Middle East Healthcare & Life Sciences Industry
MedTech sector domestic manufacturing will gradually take over in the Gulf Cooperation Council (GCC) region. GCC countries will witness hospital investments in digital health infrastructure. Focus on localization (vision 2030 in KSA & MoHAP UAE) alongside expedited drug approval in the GCC region will attract greater investments from Pharma MNCs. Artificial intelligence (AI) in the radiology value chain will be driven by hospital investments in GCC. As IVD moves towards decentralized testing, there will be an increasing demand for respiratory pathogen panel testing in the GCC region.
Verista Awarded by Frost & Sullivan for Providing Next-Generation Compliance and Quality Management Solutions in the Life Sciences Industry
Frost & Sullivan analyzed the life sciences quality management and compliance solutions and services landscape and based on its findings, recognizes Verista with the 2023 Global Customer Value Leadership Award. Verista is a world-leading business and technology consulting firm that delivers groundbreaking end-to-end solutions to life sciences companies.
Clarius Applauded by Frost & Sullivan with the Company of the Year Award for Its Handheld Ultrasound Systems
Frost & Sullivan assessed the ultraportable ultrasound industry and, based on its findings, recognizes Clarius with the 2023 North American Company of the Year Award. The company focuses on developing and producing cutting-edge handheld ultrasound technologies. It has become a notable player in the industry with the ability to deliver exceptional hospital-grade performance cost-effectively.
TeraRecon Applauded by Frost & Sullivan for Solving Time-related Challenges in Neurological Care
Frost & Sullivan examined the artificial intelligence-based neurological solutions industry and, based on its analysis, recognizes TeraRecon, a ConcertAI company, with the 2023 Global Company of the Year Award. The US-based company operates in more than 74 countries and offers AI-empowered solutions for radiology, oncology, cardiology, vascular surgery, and neurology.
Precision Health
Growth Opportunities in Global Precision Health: Integrating Radiology, Pathology, & Genomics for Precision Diagnostics
Oct 5th, 2023 9:00 AM EDT
Chronic Care
Geographic Expansion in Global Chronic Care: Bridging the Healthcare Divide - Innovative Solutions for Emerging Economies
Oct 12th, 2023 11:00 AM EDT
Technology Strategies
Revolutionizing Technology Strategies in This New Era - Advancements in Low-Carbon Fuels: Cross-Industry Developments
Oct 13th, 2023 10:00 AM EDT
Healthcare IT
Growth Opportunities in Global Healthcare IT: Digital Health Investment and Expansion: Where is the Money Going?
Oct 19th, 2023 11:00 AM EDT
Manufacturing Supply Chain
Growth Opportunities in Global Manufacturing: How Do You Build a Sustainable Manufacturing Unit?
Oct 20th, 2023 10:30 AM EDT
.png)
